Partech Announces the Closing of Its Second Growth Fund, Partech Growth II, at $750M.
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Trustpage Announces $5 Million Round to Transform How Companies Build Trust
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Bessemer Venture Partners Raises $220 Million to Back Founders in India
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Quell Therapeutics Raises $156 million in Oversubscribed Series B Financing to Advance its Pioneering Multi-Modular Engineered T Regulatory (Treg) Cell Therapy Pipeline and Platform
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Lightspeed China Partners Raises $920 Million with Focus on Green Tech, Deep Tech and Enterprise Technologies
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Armis, the most comprehensive asset cybersecurity leader, now valued at $3.4 billion
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
FINTRX Raises $9M Series A to Accelerate Growth of Its Leading Family Office & Registered Investment Advisor Data Intelligence Platform
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Clearlake Capital to Acquire Global Cybersecurity, Data Intelligence and IT Operations Management Software Leader Quest from Francisco Partners
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Column Tax Raises $5.1 Million to Accelerate Product Development
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.